S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|UPDATE: Glaxo slides in London after earnings warning|
|UPDATE: Glaxo shares fall in London after earnings warning|
|GSK Announces Results of Late-Stage PAH Trial With Gilead (2014/9/8)|
|FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States|
|GSK and Genmab announce top-line results from a Phase III study of ofatumumab versus physicians' choice for bulky fludarabine-refractory CLL|
|GSK and Genmab Receive EU Authorization for Arzerra(tm) (ofatumumab) as First-Line Treatment for Chronic Lymphocytic Leukemia (CLL) in Combination with Chlorambucil or Bendamustine for Patients Ineligible for Fludarabine-based Therapy|
|UPDATE: FTSE 100 slumps for third day as miners, banks slump (2014/8/1)|
|UPDATE: Reckitt Benckiser leads U.K.'s FTSE 100 to small gain (2014/7/28)|
|UPDATE: European stocks jump after strong U.K., Chinese data (2014/7/16)|
|UPDATE: FTSE 100 erases gain after soft U.S. home sales data (2014/7/28)|
Click above to view more mutual fund data and stats for glaxf - GlaxoSmithKline PLC.